Alfacell denied skirting FDA regulations.
In a letter to the Food and Drug Administration, the Bloomfield, N.J.-based company said it did not try to circumvent FDA regulations in shipping its test substance Pannon (an anti-tumor agent) to the Dominican Republic. Alfacell told the FDA that it will apply for permission to export Pannon for the purpose of scientific investigation.
More to Read
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
